Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells

British Journal of Cancer

Volumn 91, Issue 2, 2004, Pages 333-338

  Berge, G ^a   Ovrebo S ^a   Botnen, I V ^a   Hewer, A ^b   Phillips, D H ^b   Haugen, A ^a   Mollerup, S ^a  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Cytochrome P450; DNA adducts; Human bronchial epithelial cells; Metabolites; PAH; Real time RT PCR; Resveratrol

Indexed keywords

BENZO[A]PYRENE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; MESSENGER RNA; RESVERATROL;

ARTICLE; BRONCHUS MUCOSA; CELL LINE; DNA ADDUCT; ENZYME INHIBITION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; METABOLITE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 3843129735     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601898     Document Type: Article

References (36)

1. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H (2001) Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 7: 1466-1473
2. Bilello KS, Murin S, Matthay RA (2002) Epidemiology, etiology, and prevention of lung cancer. Clin Chest Med 23: 1-25
3. Carbo N, Costelli P, Baccino FM, Lopez-Soriano FJ, Argiles JM (1999) Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun 254: 739-743
4. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, Savouret JF (1999) Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 56: 784-790
5. Chang TK, Lee WB, Ko HH (2000) Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1. Can.J Physiol Pharmacol 78: 874-881
6. Chun YJ, Kim MY, Guengerich FP (1999) Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 262: 20-24
7. Ciolino HP, Yeh GC (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 56: 760-767
8. Denissenko MF, Pao A, Tang M, Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274: 430-432
9. De Stefani E, Correa P, Deneo-Pellegrini H, Boffetta P, Gutierrez LP, Ronco A, Brennan P, Mendilaharsu M (2002) Alcohol intake and risk of adenocarcinoma of the lung. A case-control study in Uruguay. Lung Cancer 38: 9-14
10. Ding X, Kaminsky LS (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43: 149-173
11. Ferry-Dumazet H, Garnier O, Mamani-Matsuda M, Vercauteren J, Belloc F, Billiard C, Dupouy M, Thiolat D, Kolb JP, Marit G, Reiffers J, Mossalayi MD (2002) Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23: 1327-1333
12. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421: 277-279
13. Fremont L (2000) Biological effects of resveratrol. Life Sci 66: 663-673
14. Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3: 733-744
15. Huang C, Ma WY, Goranson A, Dong Z (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20: 237-242
16. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ (2000) Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 47: 549-555
17. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220
18. Kimura Y, Okuda H (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131: 1844-1849
19. Kuper H, Adami HO, Boffetta P (2002) Tobacco use, cancer causation and public health impact. J Intern Med 251: 455-466
20. Lee JE, Safe S (2001) Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells. Biochem Pharmacol 62: 1113-1124
21. Mahyar-Roemer M, Katsen A, Mestres P, Roemer K (2001) Resveratrol induces colon tumor cell apoptosis independently of p53 and preceded by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. Int J Cancer 94: 615-622
22. Mgbonyebi OP, Russo J, Russo IH (1998) Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 12: 865-869
23. Mollerup S, Ovrebo S, Haugen A (2001) Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int J Cancer 92: 18-25
24. Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A (1999) Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59: 3317-3320
25. Narayanan BA, Narayanan NK, Re GG, Nixon DW (2003) Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer 104: 204-212
26. Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C, Doll R (1996) Mortality from smoking worldwide. Br Med Bull 52: 12-21
27. Phillips DH, Hewer A, Martin CN, Garner RC, King MM (1988) Correlation of DNA adduct levels in human lung with cigarette smoking. Nature 336: 790-792
28. Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, Vincze I (1990) Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer 46: 569-575
29. Prescott E, Gronbaek M, Becker U, Sorensen TI (1999) Alcohol intake and the risk of lung cancer: influence of type of alcoholic beverage. Am J Epidemiol 149: 463-470
30. Ray PS, Maulik G, Cordis GA, Bertelli AAE, Bertelli A, Das DK (1999) The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 27: 160-169
31. Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526
32. Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, Savouret JF, Casper RF (2003) Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol 23: 255-261
33. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273: 21875-21882
34. Sun NJ, Woo SH, Cassady JM, Snapka RM (1998) DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 61: 362-366
35. Tong L, Spitz MR, Fueger JJ, Amos CA (1996) Lung carcinoma in former smokers. Cancer 78: 1004-1010
36. Wiencke JK, Thurston SW, Kelsey KT, Varkonyi A, Wain JC, Mark EJ, Christiani DC (1999) Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst 91: 614-619